Biomerica Inc (BMRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 05/31
| 08-2024 | 05-2024 | 02-2024 | 11-2023 | 08-2023 | |
| Sales | 1,807 | 1,118 | 1,017 | 1,567 | 1,713 |
| Cost of Goods | 1,518 | 1,095 | 1,166 | 1,242 | 1,301 |
| Gross Profit | 289 | 23 | -149 | 325 | 412 |
| Operating Expenses | 2,175 | 1,645 | 2,017 | 2,175 | 1,945 |
| Operating Income | -1,368 | -1,527 | -2,000 | -1,608 | -1,232 |
| Other Income | 56 | 113 | 86 | 109 | 123 |
| Pre-tax Income | -1,312 | -1,414 | -1,914 | -1,499 | -1,109 |
| Income Tax | 4 | 7 | 4 | 8 | 23 |
| Net Income Continuous | -1,316 | -1,421 | -1,918 | -1,507 | -1,132 |
| Net Income | $-1,316 | $-1,421 | $-1,918 | $-1,507 | $-1,132 |
| EPS Basic Total Ops | -0.63 | -0.68 | -0.88 | -0.72 | -0.56 |
| EPS Basic Continuous Ops | -0.63 | -0.68 | -0.91 | -0.72 | -0.54 |
| EPS Diluted Total Ops | -0.63 | -0.68 | -0.88 | -0.72 | -0.56 |
| EPS Diluted Continuous Ops | -0.63 | -0.68 | -0.91 | -0.72 | -0.54 |
| EPS Diluted Before Non-Recurring Items | -0.64 | -0.72 | -0.88 | N/A | N/A |
| EBITDA(a) | $-1,271 | $-1,430 | $-1,906 | $-1,517 | $-1,140 |